Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Profound Medical's Q2 2026 financial results for the quarter ended June 30, 2026. The press release reports total revenue of $2.5 million (up 12% YoY, or 153% excluding shipment timing), gross margin of 78%, operating expenses declining 16%, and net loss improving 39% to $9.5 million. The company also reiterates full-year 2026 revenue guidance of $25.0 million. The filing includes condensed consolidated balance sheets and is furnished as Exhibit 99.1 to Item 2.02, which is the standard Item for results of operations and financial condition.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-06
EX-99.1
This is a press release disclosing Cellectis' financial results for the second quarter 2026 (six-month period ended June 30, 2026), including consolidated statements of financial position, operations, and per-share metrics. The document presents both interim financial statements and operational updates on clinical trials (lasme-cel, eti-cel), regulatory milestones (FDA RMAT designation), and cash position ($169 million). As a clinical-stage biotech company, these results and regulatory developments are material to investors assessing the registrant's progress and financial runway.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-06
Item 5.02
Anthony J. Salgado was appointed Chief Operating Officer of Hyster-Yale, Inc. effective August 1, 2026, representing a material executive appointment. Although Mr. Salgado previously served as President and CEO of the principal operating subsidiary, his elevation to COO at the parent company level is a significant leadership change that would affect investor assessment of the company's governance and operational structure.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 95%
filed 2026-08-06
Item 8.01
IEH Corporation disclosed a material cybersecurity incident involving unauthorized access to a Microsoft 365 mailbox through a phishing attack on August 4, 2026. The threat actor gained access to sensitive information including customer communications, purchase orders, engineering documentation, and potentially export-controlled technical information. Although the company states no evidence currently exists of data exfiltration or unauthorized transmission, the disclosure of unauthorized access to sensitive business and technical information, combined with the company's investigation and corrective actions, constitutes a material cybersecurity incident reportable under Item 1.05 (or Item 8.01 as presented here).
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-06
EX-99
This exhibit announces the results of Elbit Systems' Annual General Meeting of Shareholders held on August 5, 2026. The disclosure reports approval of five specific resolutions: election of seven board members, re-election of an external director, extension of indemnification and exemption letters for two executives, and re-appointment of the independent auditor. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, reporting outcomes of a formal shareholder vote on material governance matters including board composition and auditor appointment.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-06
EX-99.1
NICE has been designated as a launch partner for AWS European Sovereign Cloud and will make its agentic AI customer experience solution available on that platform, extending its product reach into regulated European markets with data residency and digital sovereignty compliance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-06
EX-99.6
NICE has expanded its strategic partnership with RingCentral through a new multi-year resale agreement for RingCentral's UCaaS solution (RingEX) and an extension of their existing contact-center agreement, creating integrated offerings and revenue opportunities.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-06
EX-99.5
Banco do Brasil, a major Latin American financial institution serving 90+ million customers, has embedded NICE Copilot into its core banking workflows, demonstrating significant customer adoption and revenue-generating deployment of the company's flagship AI platform at scale in a major financial services market.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-06
EX-99.1
Nayax announced the filing of an application to establish Nayax America Bank Inc., a non-depository innovation bank in Connecticut, and the launch of Yellow Account with Adyen as sponsoring bank. This represents a material strategic expansion into regulated banking infrastructure and embedded financial services (corporate cards, credit products, working capital solutions) that would deepen customer relationships and capture a larger share of financial activity. While not a discrete M&A transaction or governance change, this operational and regulatory milestone materially expands the company's service offerings and business model in its largest market (40% of global revenue).
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-06
This is a press release announcing Nova's second quarter 2026 financial results, including record quarterly revenue of $255.0 million (up 16% YoY), record GAAP net income of $75.0 million ($2.20 per diluted share), and record non-GAAP net income of $86.5 million ($2.51 per diluted share). The release includes detailed financial statements, management commentary, and forward guidance for Q3 2026. This is a classic earnings release disclosing quarterly results, material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-06
EX-99
This exhibit is a press release announcing MIND CTI's second quarter 2026 financial results, including revenues of $4.6 million, operating income of $0.7 million, and net income of $0.8 million ($0.04 per share), along with six-month comparative results. The document includes condensed consolidated financial statements (income statement, balance sheet, and cash flow statement) and management commentary. While the exhibit also discloses two Nasdaq compliance notifications (minimum bid price deficiency and audit committee composition), the primary and dominant disclosure is the quarterly earnings announcement, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-08-06
The 6-K discloses the results of monday.com's annual general meeting of shareholders held on August 6, 2026, including voting outcomes on five proposals: re-election of three Class II directors (Eran Zinman, Aviad Eyal, and Petra Jenner), approval of the Compensation Policy for Executive Officers and Directors, approval of the Co-CEO Compensation Package, approval of the Non-Employee Director Compensation Package, and re-appointment of the independent auditor. The document presents detailed vote tallies and approval percentages for each proposal, which is the core disclosure required under Item 5.07 (shareholder vote results).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-06
The filing discloses results of T3 Defense Inc.'s annual meeting of stockholders held on August 5, 2026, under Item 5.07. Three proposals were voted on: election of four directors (Menachem Shalom, Shiran Fridman, Tomer Nagar, and Asaf Nachum), ratification of Somekh Chaikin as independent auditors, and approval of the 2026 Evergreen Equity Incentive Plan. All three proposals passed with detailed vote tallies provided, making this a clear shareholder vote results disclosure that is material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
PRA Group issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, including net income of $58 million, diluted EPS of $1.51, total cash collections of $559 million (up 4%), and adjusted EBITDA of $1.4 billion (up 10%). The company also disclosed details of a webcast and conference call to discuss the Q2 2026 results.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-06
Item 8.01
The Board of Directors approved a share repurchase program authorizing up to $150 million in repurchases of outstanding common stock, representing a material capital return initiative to shareholders.
View raw filing on EDGAR →
6-K
Earnings release
confidence 97%
filed 2026-08-06
EX-99.1
Amdocs Limited reported third quarter fiscal 2026 financial results with revenue of $1.175 billion (up 2.7% year-over-year), GAAP diluted EPS of $0.59, and non-GAAP diluted EPS of $1.84, along with updated guidance and management commentary on operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
LifeStance issued a press release on August 6, 2026 announcing Q2 2026 financial results, including revenue of $435.4 million (26% YoY growth), net income of $23.6 million (vs. prior-year loss of $3.8 million), and Adjusted EBITDA of $66.0 million, along with raised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-06
Item 8.01
The Board of Directors approved a $100 million share repurchase program on August 5, 2026, replacing a prior $100 million program, representing a significant capital return to shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
TTM Technologies disclosed second quarter 2026 financial results via press release attached as Exhibit 99.1, reporting net sales of $1.0 billion (up 37% year-over-year, an all-time quarterly record), GAAP net income of $83.0 million ($0.77 per diluted share), and non-GAAP net income of $106.9 million ($0.99 per diluted share, also an all-time quarterly record). The filing includes detailed financial statements, segment data, and forward guidance for Q3 and full-year 2026. This is a standard Item 2.02 earnings release disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-06
Item 8.01
The Company agreed to issue $1.0 billion in aggregate principal amount of senior notes ($600 million 2031 Notes at 4.950% and $400 million 2036 Notes at 5.450%) pursuant to a Terms Agreement dated August 4, 2026. This is a material creation of direct financial obligations disclosed under Item 8.01, representing a significant debt issuance by the operating partnership of Equity Residential.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-08-06
EX-99.1
The exhibit is a press release announcing that Nutrien's Board of Directors has declared a quarterly dividend of US$0.55 per share, payable on October 16, 2026, to shareholders of record on September 29, 2026. This is a straightforward dividend declaration, which falls squarely within the dividend_distribution event type. The disclosure is material as it represents a return of capital to shareholders and affects investor valuation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
First Advantage issued a press release on August 6, 2026 announcing Q2 2026 financial results, with revenues of $448.8 million (14.9% YoY growth), net income of $16.9 million, and raised full-year 2026 guidance across multiple metrics.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-06
Item 5.02
Sharon Binger was appointed as a Class I director effective August 6, 2026 and simultaneously appointed to the Nominating and Corporate Governance Committee, with the Board increasing its size to nine directors to accommodate this appointment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Generate Biomedicines issued a press release on August 6, 2026, reporting financial results for the quarter ended June 30, 2026, including revenue of $6.3 million, R&D expenses of $64.3 million, net loss of $67.3 million, and cash position of $457.4 million. The filing includes condensed consolidated balance sheets and statements of operations with comparative periods, which are hallmarks of a quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-08-06
Item 2.03
Yum China entered into a Bridge Credit Agreement on July 31, 2026, establishing a senior unsecured term loan facility of CNH 8.4 billion to finance a material acquisition from Yum! Brands, Inc., creating a new direct financial obligation.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-06
Item 2.03
The company entered into a Fifth Amendment to its credit facility that refinances existing term loans of $763.961 million and modifies the interest rate structure, including a 50 basis point reduction in interest rates on the term loan, materially affecting the company's debt service costs.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-08-06
SK hynix clarifies media reports that its U.S. subsidiary Solidigm is pursuing a pre-IPO capital raise of approximately Won 5 trillion. While the Company states no matters have been determined, the disclosure of a potential material capital-raising initiative by a major subsidiary—even in clarification form—constitutes an operational/strategic event that would affect investor assessment. The materiality and specificity of the reported amount (Won 5 trillion) and the subsidiary's strategic importance warrant classification as material, though the preliminary nature and lack of confirmed details prevent assignment to a more specific event type like `dilutive_issuance` or `ma_activity`.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-06
EX-99.1
This press release announces European Commission approval of an expanded indication for MenQuadfi (meningococcal vaccine) to include infants from six weeks of age, a significant regulatory milestone for a marketed product. While not a discrete M&A, financial, or governance event, the regulatory approval of a major label expansion for a vaccine addressing a serious public health threat represents a material operational and commercial development that would affect investor assessment of Sanofi's vaccine portfolio and market opportunities.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-08-06
This 6-K furnishes ORIX Corporation's consolidated financial results for the first quarter ended June 30, 2026 (April 1 – June 30, 2026), filed with the Tokyo Stock Exchange on August 6, 2026. The document presents quarterly financial statements including income statement, balance sheet, segment information, and forward-looking guidance, consistent with a periodic quarterly financial report. Although the filing includes a dividend revision and forecast updates, the core disclosure is the quarterly financial report itself, which should be classified as a periodic event rather than as discrete earnings-release or dividend events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Geron Corporation issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, including Q2 2026 net product revenue of $57.5 million, net loss of $16.7 million, and 2026 full-year financial guidance. The disclosure is a standard quarterly earnings announcement with detailed financial results and business highlights, filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
MidCap Financial Investment Corporation disclosed its quarterly financial results for the period ended June 30, 2026 via a press release furnished as Exhibit 99.1. The disclosure includes net investment income per share ($0.40), NAV per share ($13.37), portfolio activity, operating results, and other financial metrics typical of an earnings release. This is a standard Item 2.02 earnings disclosure for a BDC (Business Development Company) and is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-08-06
This 6-K furnishes a "Supplement for Financial Highlights – Three months ended June 30, 2026," presenting unaudited consolidated quarterly financial results including net revenue (686.7 billion yen), net income (145.6 billion yen), balance sheet metrics, capital ratios, and detailed segment performance data. The document explicitly states it covers "the three months ended June 30, 2026" and includes comprehensive financial position, KPIs, and business segment information typical of a quarterly earnings report. This is a periodic quarterly financial report itself, not a discrete event announcement, and should be deferred for separate processing rather than classified as an earnings_release event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-06
EX-99.1
The exhibit announces the results of China Yuchai International's Annual General Meeting held on August 6, 2026, stating that "all the resolutions as set out in its Notice of Annual General Meeting dated July 7, 2026 were duly passed." This is a direct disclosure of shareholder vote results at an annual meeting, which is material to investors as it confirms governance actions and shareholder approval of company matters.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Targa Resources Corp. disclosed its financial results for the three and six months ended June 30, 2026, reporting net income of $765 million (up 22% year-over-year) and record adjusted EBITDA of $1,603 million (up 38%), along with updated full-year 2026 guidance and detailed segment performance analysis.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
GEO Group issued a press release on August 6, 2026, announcing second quarter 2026 financial results (revenues of $732.1 million, net income of $47.5 million), updated full-year 2026 guidance (revenues $2.95-$3.05 billion, net income $168-$175 million), and provided Q3 and Q4 2026 guidance. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Leggett & Platt issued a press release on August 6, 2026 announcing its financial results for the second quarter ending June 30, 2026, reporting Q2 sales of $1.0 billion (down 6% YoY), EPS of $0.33, and adjusted EPS of $0.39 (up $0.09 vs. prior year), along with segment-level results and withdrawal of forward guidance due to the pending Somnigroup merger.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
NexPoint Real Estate Finance issued a press release on August 6, 2026, announcing its financial results for the second quarter ended June 30, 2026. The disclosure reports net income attributable to common stockholders of $5.4 million ($0.29 per diluted share), cash available for distribution of $13.9 million ($0.58 per diluted common share), and provides third quarter 2026 guidance. This is a standard quarterly earnings release with detailed financial metrics and forward guidance, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Graham Corporation issued a press release on August 6, 2026, disclosing first quarter fiscal 2027 financial results, including record net sales of $71.3 million (up 29%), net income per diluted share of $0.33, and record backlog of $557.2 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Palladyne AI issued a press release announcing its financial results for Q2 2026 and the six months ended June 30, 2026, disclosing revenue of $5.8 million (470% YoY growth), an operating loss of $13.4 million, and a net loss of $0.27 per share, along with strategic highlights including new contract awards of $13.0 million and backlog of $24.6 million, with full-year 2026 guidance of $24-27 million in revenue.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-06
Item 1.01
Lithium Americas entered into a Securities Purchase Agreement with Yorkville Advisors (YA II PN, Ltd.) to issue up to $175 million in subordinated convertible debentures, with an initial $150 million closing upon filing its Q2 10-Q and an option for an additional $25 million. The debentures have a 5-year maturity, 5% base interest rate, and conversion features, with proceeds designated for general corporate purposes including capital expenditures and debt repayment to support the Thacker Pass project.
View raw filing on EDGAR →
8-K
Exec departure
confidence 94%
filed 2026-08-06
Item 5.02
Parag D. Desai, Senior Vice President and Chief Strategy and Digital Officer, is departing the Company effective October 31, 2026, after more than a decade of service. He will transition to part-time status effective August 7, 2026, and cease serving as an executive officer before his final retirement. The filing emphasizes his significant contributions to the Company's strategic direction, technology transformation, and execution of the Footwear First strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
DNOW Inc. issued a press release on August 6, 2026 announcing second-quarter 2026 earnings results for the period ended June 30, 2026, including revenue of $1,307 million, adjusted EBITDA of $60 million, and net loss of $21 million. The filing explicitly states "DNOW Inc. issued a press release announcing earnings for the quarter ended June 30, 2026" and furnishes the earnings announcement as Exhibit 99.1, which is the standard disclosure mechanism for quarterly financial results under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Evergy issued a press release on August 6, 2026, announcing second quarter 2026 financial results with GAAP EPS of $0.91 and adjusted EPS of $0.88, compared to prior-year results of $0.74 and $0.82 respectively. The company reaffirmed full-year 2026 adjusted EPS guidance of $4.14 to $4.34 and declared a dividend.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Liquidity Services' financial results for the fiscal quarter ended June 30, 2026. The press release (Exhibit 99.1) announces quarterly financial metrics including GMV of $453.0 million (up 10%), revenue of $129.6 million (up 8%), GAAP net income of $10.4 million (up 41%), and diluted EPS of $0.32 (up 39%), along with segment results and forward guidance for Q4-FY26. This is a standard Item 2.02 earnings disclosure that would materially affect a reasonable investor's assessment of the company's financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-06
EX-99.2
This is a press release announcing Genius Sports' second quarter 2026 financial results, including revenue of $195.5 million (beating guidance of $185 million), net loss of $76.7 million, and adjusted EBITDA of $52.6 million (beating guidance of $45 million). The company also raised its full-year 2026 revenue and adjusted EBITDA guidance. The exhibit includes condensed consolidated financial statements, cash flow statements, and reconciliation tables typical of an earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-06
Dana Incorporated disclosed its second-quarter 2026 financial results via a press release attached as Exhibit 99.1, reporting sales of $2.01 billion (up 4% YoY), adjusted EBITDA of $207 million with a 10.3% margin (up 270 basis points), and increased full-year guidance. The filing explicitly states "Dana Incorporated today issued a news release announcing its results for the quarter ended June 30, 2026" under Items 2.02 and 7.01, which is the standard disclosure mechanism for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
TripAdvisor issued a press release on August 6, 2026 announcing preliminary financial results for Q2 and H1 2026, disclosing revenue of $441.9 million (down 7% YoY), net income of $22.8 million ($0.19 diluted EPS), and adjusted EBITDA of $76.4 million. The filing explicitly states this is an earnings announcement with the full press release furnished as Exhibit 99.1, which is the standard format for earnings releases under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Amylyx Pharmaceuticals issued a press release on August 6, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing R&D expenses ($23.8M), SG&A expenses ($21.9M), net loss ($43.4M or $0.39 per share), and cash position ($250.8M). The filing is made under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Nexstar Media Group issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing record quarterly net revenue of $2.0 billion, net income of $113 million, and adjusted EBITDA of $633 million. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the typical disclosure mechanism for earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Monte Rosa Therapeutics announced its financial results for the quarter ended June 30, 2026, on August 6, 2026. The disclosure includes quarterly financial metrics (collaboration revenue of $9.0 million, R&D expenses of $48.0 million, G&A expenses of $10.1 million, net loss of $43.4 million) and cash position ($626.0 million), along with business highlights and clinical program updates. This is a standard quarterly earnings release furnished as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →